Prokidney (PROK) Long-Term Debt Issuances (2021 - 2022)

Prokidney (PROK) reported Long-Term Debt Issuances of $15.0 million for Q2 2022, up 4900.0% year-over-year from $300000.0 in Q2 2021, and down 25.0% quarter-over-quarter from $20.0 million in Q1 2022.

Prokidney (PROK) Long-Term Debt Issuances (2021 - 2022) Analysis & Trends

Prokidney (PROK) has 2 years of Long-Term Debt Issuances data on file, last reported at $15.0 million in Q2 2022.

  • Long-Term Debt Issuances for Q2 2022 came in at $15.0 million, up 4900.0% year-over-year; the trailing twelve-month figure through Mar 2023 was $15.0 million (down 28.23% YoY), and the FY2022 annual result was $35.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances slipped to $15.0 million in Q2 2022 per PROK's latest filing, from $20.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $20.0 million in Q1 2022 and troughed at $255.0 in Q1 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.73 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prokidney 259.01 Mn 1.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 15.00 Mn
Jun 30, 2022 15.00 Mn
Mar 31, 2022 20.00 Mn
Mar 31, 2022 20.00 Mn
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Mar 31, 2021 255.00
Mar 31, 2021 255.00